Inaugural O'Donnell Brain Institute Symposium: Autism Spectrum Disorders (RP2103C)

March 25, 2021 to March 26, 2021

Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders, affecting one in fifty-five children in the United States. This symposium aims to update the community on new discoveries in the pathophysiology and causes of ASD as well as emerging novel treatments. The symposium will: 1) review novel ways to assess and characterize clinical features of patients with ASD, 2) review neural circuit mechanisms in both humans and animal models of ASD, 3) review insights gained from studying syndromic ASD, and 4) review novel treatments for ASD.  Attendees will gain an understanding of the current state of research in the underlying pathophysiology of ASD as well as novel treatments to target those mechanisms.

CLICK HERE FOR E-BROCHURE (Includes )Agenda with Speakers

CLICK HERE FOR POSTER SESSIONS SCHEDULE 

 

Target Audience

This symposium is designed for and open to all involved in autism research and clinical care of Autism Spectrum Disorders. 

Learning Objectives

Session 1: To provide knowledge on the clinical phenotyping, genotyping, and biomarker development for ASD.

Session 2: To provide knowledge on the critical neural circuits that contribute to neurodevelopmental disabilities and behavior in ASD.

Session 3: To provide knowledge of the clinical presentation, disease mechanisms and latest research and treatment strategies for syndromic autisms.

Session 4: To provide knowledge on the novel treatments being developed for ASD such as gene replacement therapy, cerebellar circuit modulation, and neuropsychopharmacology.

Course summary
Available credit: 
  • 14.50 AMA
  • 14.50 Attendance
Course opens: 
01/12/2021
Course expires: 
03/26/2022
Event starts: 
03/25/2021 - 8:00am
Event ends: 
03/26/2021 - 5:00pm
Cost:
$0.00
Rating: 
0

CLICK HERE FOR CME HANDOUT (agenda, learning objectives, speaker disclosures, and more)

 

RESOURCES (select an item to access file)

 

DAY ONE - Thursday, March 25, 2021

Session 1 addresses the gap in clinical phenotyping, genotyping, and biomarker development in ASD. This session will also address racial disparities that exist in healthcare delivery and clinical research in ASD.

Session 2 addresses the knowledge gap in neural circuit dysfunction in neurodevelopmental disorders, including ASD. It will update attendees on which circuits are involved in ASD and how identified circuit dysfunction may impact behavior.

DAY TWO - Friday, March 26, 2021

Session 3 addresses the knowledge gap in the forms of ASD that are classified as “syndromic” autism that are typically caused by loss of function mutations in single genes. Examples of these are:  Fragile X Syndrome, Rett Syndrome, Phelan-McDermid Syndrome and Tuberous Sclerosis. Diagnosis and treatment of the different forms and genetic causes of autism requires clinicians to be educated in their clinical presentation, causes and the latest treatments.  

Session 4 addresses the practice gap in novel treatments for ASD such as gene replacement therapy for monogenic forms of ASD, cerebellar circuit modulation, and small molecule and neuropsychopharmacology approaches for ASD.

Virtual Event (Zoom)
UT Southwestern Medical Center
Dallas, TX
United States

Session 1:  Advancing Assessment and Characterization of Autism

Stephen Scherer, PhD - The Hospital for Sick Children, University of Toronto

Maria Chahrour, MD - UT Southwestern Medical Center

Sarah Webb, PhD - University of Washington, Seattle Children's Research Institute

Jed Elison, PhD - University of Minnesota, Institute of Child Development

Matthew Mosconi, PhD - University of Kansas Center for Autism Research and Training

Patricia Evans, MD, PhD - UT Southwestern Medical Center; Children's Medical Center Dallas

           

Session 2:  Neural Circuit Mechanisms in Autism: Humans and Animal Models

Shafali Jeste, MD - UCLA School of Medicine and Center for Autism Research and Treatment

Lauren Orefice, PhD - Harvard Medical School; Massachusetts General Hospital

Jason Lerch, PhD - Oxford University; Wellcome Centre for Integrative Neuroimaging

Michela Fagiolini, PhD - Harvard Medical School; Boston Children's Hospital

Kimberly Huber, PhD - UT Southwestern Medical Center

Genevieve Konopka, PhD - UT Southwestern Medical Center

           

Session 3:  Insights from Syndromic Autism; Humans and Animal Models

Mustafa Sahin, MD, PhD - Harvard Medical School; Boston Children's Hospital

Ben Philpot, PhD - University of North Carolina, Chapel Hill

Mark Bear, PhD - Massachusetts Institute of Technology; Picower Institute for Learning and Memory

Ype Elgersma, PhD - Erasmus Medical Center, Netherlands

Guoping Feng, PhD – Massachusetts Institute of Technology; McGovern Institute

           

Session 4:  Therapeutic Opportunities for Autism

Steven Gray, PhD - UT Southwestern Medical Center

Kimberly Goodspeed, MD - UT Southwestern Medical Center

Peter Tsai MD, PhD - UT Southwestern Medical Center

Catherine Stoodley, DPhil - American University

Craig Erickson, MD - Cincinnati Chidren's Hospital; University of Cincinnati

Evdokia Anagnostou, MD - Holland Bloorview Kids Rehabilitation Hospital, University of Toronto

 

ASD Symposium Planning Committee

Kimberly Huber, PhD (Course Director) - UT Southwestern Medical Center

Peter Tsai, MD, PhD - UT Southwestern Medical Center

Patricia Evans, MD, PhD - UT Southwestern Medical Center

Kimberly Goodspeed, MD - UT Southwestern Medical Center

William T. Dauer, MD - Director, Peter O’Donnell Jr. Brain Institute

Vicki Dennis – Associate Vice President, Peter O’Donnell Jr. Brain Institute

Mark Vinciguerra - Program Coordinator, UT Southwestern Office of CME

Accreditation

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The University of Texas Southwestern Medical Center designates this continuing education activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for a maximum of 14.5 AMA PRA Category 1 Credits™.

Available Credit

  • 14.50 AMA
  • 14.50 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.

THERE IS NO CHARGE TO ATTEND THIS SYMPOSIUM.

To register:

  1. "Login" to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

 

 

Required Hardware/software

Operating System

  • Windows 7 - Windows 10
  • Mac OS X 10.9 (Mavericks) - macOS Catalina (10.15)
  • Linux
  • Google Chrome OS
  • Android OS 5 (Lollipop) - Android 9 (Pie)
  • iOS 10 - iOS 12
  • Windows Phone 8+, Windows 8RT+

     Web browser

  • Google Chrome (most recent 2 versions)
  • Mozilla Firefox (most recent 2 versions

      Internet connection

  • Computer: 1 Mbps or better (broadband recommended)
  • Mobile device: 3G or better (WiFi recommended for VoIP audio)

      Software

  • GoToWebinar desktop app
  • GoToWebinar mobile app
  • JavaScript enabled

      Hardware

  • Microphone and speakers (USB headset recommended)

      Mobile device

  • iPhone 4S or later
  • iPad 2 or later
  • Android OS 5 (Lollipop) - Android 9 (Pie)